Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort

Early noninvasive reliable biomarkers are among the major unmet needs in Parkinson’s disease (PD) to monitor therapy response and disease progression. Objective measures of motor performances could allow phenotyping of subtle, undetectable, early stage motor impairments of PD patients. This work aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lazzaro, Giulia, Ricci, Mariachiara, Saggio, Giovanni, Costantini, Giovanni, Schirinzi, Tommaso, Alwardat, Mohammad, Pietrosanti, Luca, Patera, Martina, Scalise, Simona, Giannini, Franco, Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448861/
https://www.ncbi.nlm.nih.gov/pubmed/34535672
http://dx.doi.org/10.1038/s41531-021-00227-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448861/
https://www.ncbi.nlm.nih.gov/pubmed/34535672
http://dx.doi.org/10.1038/s41531-021-00227-1

Ejemplares similares